IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,155,000 | +32.7% | 179,601 | +38.3% | 0.75% | -15.8% |
| Q2 2020 | $7,655,000 | -17.3% | 129,832 | -33.7% | 0.89% | -43.6% |
| Q1 2020 | $9,260,000 | -37.1% | 195,850 | -19.6% | 1.58% | -16.0% |
| Q4 2019 | $14,721,000 | -24.3% | 243,691 | -24.9% | 1.88% | -36.0% |
| Q3 2019 | $19,450,000 | -7.5% | 324,649 | -0.8% | 2.94% | +0.7% |
| Q2 2019 | $21,025,000 | -57.6% | 327,132 | -46.5% | 2.92% | -54.7% |
| Q1 2019 | $49,608,000 | +55.5% | 611,162 | +3.6% | 6.45% | +26.8% |
| Q4 2018 | $31,896,000 | +25.6% | 590,010 | +19.9% | 5.08% | +24.1% |
| Q3 2018 | $25,385,000 | +23.2% | 492,140 | -0.4% | 4.10% | +27.7% |
| Q2 2018 | $20,599,000 | +1000.4% | 494,347 | +1064.2% | 3.21% | +680.3% |
| Q1 2018 | $1,872,000 | -11.1% | 42,464 | +1.5% | 0.41% | -28.8% |
| Q4 2017 | $2,105,000 | -2.3% | 41,847 | -1.6% | 0.58% | -15.4% |
| Q3 2017 | $2,155,000 | +0.8% | 42,511 | +1.2% | 0.68% | -4.9% |
| Q2 2017 | $2,137,000 | +5.9% | 42,015 | -16.3% | 0.72% | -6.9% |
| Q1 2017 | $2,018,000 | -14.7% | 50,189 | +1.5% | 0.77% | -26.0% |
| Q4 2016 | $2,366,000 | +27.1% | 49,458 | -2.6% | 1.04% | +29.8% |
| Q3 2016 | $1,861,000 | – | 50,782 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |